295 related articles for article (PubMed ID: 17122202)
21. Hemostatic drugs.
Mannucci PM
N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
[No Abstract] [Full Text] [Related]
22. The demise of aprotinin: our share of the blame.
Sundt TM
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):729-31. PubMed ID: 18374748
[No Abstract] [Full Text] [Related]
23. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis.
Schouten ES; van de Pol AC; Schouten AN; Turner NM; Jansen NJ; Bollen CW
Pediatr Crit Care Med; 2009 Mar; 10(2):182-90. PubMed ID: 19188875
[TBL] [Abstract][Full Text] [Related]
24. Aprotinin and cardiac surgery.
DeAnda A
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
[No Abstract] [Full Text] [Related]
25. Pro: tranexamic acid is better than aprotinin in decreasing bleeding after cardiac surgery.
Guenther CR
J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):471-3. PubMed ID: 7524719
[No Abstract] [Full Text] [Related]
26. [Aprotinin in cardiac surgery: one paper of the year or a provocation from the New England Journal of Medicine].
Blanloeil Y
Ann Fr Anesth Reanim; 2006 Jul; 25(7):683-5. PubMed ID: 16919751
[No Abstract] [Full Text] [Related]
27. [Aprotinin in the control of surgical hemorrhage].
Rocha E; Antonio Páramo J; Hermida J
Med Clin (Barc); 1996 Mar; 106(8):307-16. PubMed ID: 8667690
[No Abstract] [Full Text] [Related]
28. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
[TBL] [Abstract][Full Text] [Related]
29. Con: tranexamic acid is not better than aprotinin in decreasing bleeding after cardiac surgery.
Murkin JM
J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):474-6. PubMed ID: 7524720
[No Abstract] [Full Text] [Related]
30. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
[TBL] [Abstract][Full Text] [Related]
31. Pro: aprotinin should be used in patients undergoing hypothermic circulatory arrest.
Royston D
J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):121-5. PubMed ID: 11254854
[No Abstract] [Full Text] [Related]
32. Coagulation in cardiac surgery.
Royston D
Adv Card Surg; 1996; 8():19-45. PubMed ID: 9111648
[No Abstract] [Full Text] [Related]
33. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
34. Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin.
Howell N; Senanayake E; Freemantle N; Pagano D
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):234-40. PubMed ID: 22889481
[TBL] [Abstract][Full Text] [Related]
35. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era.
Koster A; Schirmer U
Curr Opin Anaesthesiol; 2011 Feb; 24(1):92-7. PubMed ID: 20881484
[TBL] [Abstract][Full Text] [Related]
36. Antifibrinolytics in liver transplantation.
Groenland TH; Porte RJ
Int Anesthesiol Clin; 2006; 44(3):83-97. PubMed ID: 16832208
[No Abstract] [Full Text] [Related]
37. Aprotinin and renal dysfunction after pediatric cardiac surgery.
Székely A; Sápi E; Breuer T; Kertai MD; Bodor G; Vargha P; Szatmári A
Paediatr Anaesth; 2008 Feb; 18(2):151-9. PubMed ID: 18184247
[TBL] [Abstract][Full Text] [Related]
38. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
Augoustides JG
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754
[No Abstract] [Full Text] [Related]
39. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
[TBL] [Abstract][Full Text] [Related]
40. Pro: Aprotinin should be used in coronary artery bypass graft surgery with cardiopulmonary bypass.
Hill SE
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):298-301. PubMed ID: 17418753
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
